As of 2026-03-14, the Relative Valuation of Immunovant Inc (IMVT) is (55.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.41 USD, the upside of Immunovant Inc based on Relative Valuation is -327.0%.
The range of the Relative Valuation is (50.18) - (63.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 29.2x | 25.6x |
| Forward P/E multiples | 21.9x - 27.9x | 23.0x |
| Fair Price | (50.18) - (63.59) | (55.42) |
| Upside | -305.6% - -360.5% | -327.0% |
| Date | P/E |
| 2026-03-13 | -10.70 |
| 2026-03-12 | -10.96 |
| 2026-03-11 | -11.21 |
| 2026-03-10 | -11.28 |
| 2026-03-09 | -11.58 |
| 2026-03-06 | -11.69 |
| 2026-03-05 | -11.72 |
| 2026-03-04 | -11.87 |
| 2026-03-03 | -11.71 |
| 2026-03-02 | -12.17 |
| 2026-02-27 | -12.16 |
| 2026-02-26 | -12.02 |
| 2026-02-25 | -11.94 |
| 2026-02-24 | -12.01 |
| 2026-02-23 | -11.93 |
| 2026-02-20 | -11.66 |
| 2026-02-19 | -11.56 |
| 2026-02-18 | -11.68 |
| 2026-02-17 | -11.52 |
| 2026-02-13 | -11.29 |
| 2026-02-12 | -11.24 |
| 2026-02-11 | -11.37 |
| 2026-02-10 | -11.70 |
| 2026-02-09 | -12.05 |
| 2026-02-06 | -11.86 |
| 2026-02-05 | -10.55 |
| 2026-02-04 | -11.03 |
| 2026-02-03 | -11.31 |
| 2026-02-02 | -11.43 |
| 2026-01-30 | -11.40 |
| 2026-01-29 | -11.60 |
| 2026-01-28 | -11.43 |
| 2026-01-27 | -11.76 |
| 2026-01-26 | -11.66 |
| 2026-01-23 | -11.40 |
| 2026-01-22 | -11.48 |
| 2026-01-21 | -11.41 |
| 2026-01-20 | -11.46 |
| 2026-01-16 | -11.52 |
| 2026-01-15 | -11.40 |
| 2026-01-14 | -11.99 |
| 2026-01-13 | -11.48 |
| 2026-01-12 | -11.32 |
| 2026-01-09 | -11.41 |
| 2026-01-08 | -11.54 |
| 2026-01-07 | -11.72 |
| 2026-01-06 | -11.36 |
| 2026-01-05 | -10.95 |
| 2026-01-02 | -11.36 |
| 2025-12-31 | -11.15 |